RNAC Stock Earnings: Cartesian Therapeutics Misses EPS, Beats Revenue for Q1 2024
InvestorPlaceInvestorPlace – Stock Market News, Stock Advice & Trading Tips
RNAC stock results show that Cartesian Therapeutics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
The post RNAC Stock Earnings: Cart…